Buy IPA/TESA Blend 15mg

▸The Visceral Fat Reduction Stack

The IPA/TESA blend combines the FDA-validated visceral fat-reducing GHRH analog (tesamorelin) with the cleanest GH-amplifying GHRP (ipamorelin) for a comprehensive GH optimization protocol with particular emphasis on visceral adipose tissue reduction. Tesamorelin's proven 15–20% VAT reduction combined with ipamorelin's additional GH pulse amplification creates a synergistic protocol for addressing metabolically dangerous visceral fat.

▸Why Tesamorelin + Ipamorelin

Tesamorelin, as a GHRH analog, works synergistically with ipamorelin (a GHRP) through the same GHRH+GHRP complementary mechanism as CJC-1295+Ipamorelin. The addition of ipamorelin's pituitary GH trigger amplifies the GH pulses initiated by tesamorelin, potentially producing superior outcomes to tesamorelin monotherapy. Combining the FDA-approved fat reduction profile of tesamorelin with ipamorelin's clean side effect profile creates an ideal protocol for visceral fat reduction with GH optimization.

▸Target Population

This blend is ideal for middle-aged to older individuals with excess visceral fat, metabolic syndrome features, suppressed GH secretion, or those who want the benefits of the FDA-validated tesamorelin protocol augmented by Ipamorelin's synergistic GH amplification.